Suppr超能文献

UGT2B7 的精氨酸 259 赋予 UDP-糖选择性。

Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity.

机构信息

Department of Clinical Pharmacology (P.C.N., N.C., J.O.M.) and Flinders Health and Medical Research Institute (FHMRI) Cancer Program (P.C.N., R.A.M., J.O.M.), Flinders Health and Medical Research Institute, Flinders University College of Medicine and Public Health, Flinders Medical Centre, South Australia, Australia

Department of Clinical Pharmacology (P.C.N., N.C., J.O.M.) and Flinders Health and Medical Research Institute (FHMRI) Cancer Program (P.C.N., R.A.M., J.O.M.), Flinders Health and Medical Research Institute, Flinders University College of Medicine and Public Health, Flinders Medical Centre, South Australia, Australia.

出版信息

Mol Pharmacol. 2020 Dec;98(6):710-718. doi: 10.1124/molpharm.120.000104. Epub 2020 Oct 2.

Abstract

Enzymes of the human UDP-glycosyltransferase (UGT) superfamily typically catalyze the covalent addition of the sugar moiety from a UDP-sugar cofactor to relatively low-molecular weight lipophilic compounds. Although UDP-glucuronic acid (UDP-GlcUA) is most commonly employed as the cofactor by UGT1 and UGT2 family enzymes, UGT2B7 and several other enzymes can use both UDP-GlcUA and UDP-glucose (UDP-Glc), leading to the formation of glucuronide and glucoside conjugates. An investigation of UGT2B7-catalyzed morphine glycosidation indicated that glucuronidation is the principal route of metabolism because the binding affinity of UDP-GlcUA is higher than that of UDP-Glc. Currently, it is unclear which residues in the UGT2B7 cofactor binding domain are responsible for the preferential binding of UDP-GlcUA. Here, molecular dynamics (MD) simulations were performed together with site-directed mutagenesis and enzyme kinetic studies to identify residues within the UGT2B7 binding site responsible for the selective cofactor binding. MD simulations demonstrated that Arg259, which is located within the N-terminal domain, specifically interacts with UDP-GlcUA, whereby the side chain of Arg259 H-bonds and forms a salt bridge with the carboxylate group of glucuronic acid. Consistent with the MD simulations, substitution of Arg259 with Leu resulted in the loss of morphine, 4-methylumbelliferone, and zidovudine glucuronidation activity, but morphine glucosidation was preserved. SIGNIFICANCE STATEMENT: Despite the importance of uridine diphosphate glycosyltransferase (UGT) enzymes in drug and chemical metabolism, cofactor binding interactions are incompletely understood, as is the molecular basis for preferential glucuronidation by UGT1 and UGT2 family enzymes. The study demonstrated that long timescale molecular dynamics (MD) simulations with a UGT2B7 homology model can be used to identify critical binding interactions of a UGT protein with UDP-sugar cofactors. Further, the data provide a basis for the application of MD simulations to the elucidation of UGT-aglycone interactions.

摘要

人 UDP-糖基转移酶 (UGT) 超家族的酶通常催化从 UDP-糖辅因子中将糖部分共价添加到相对低分子量亲脂化合物。尽管 UDP-葡萄糖醛酸 (UDP-GlcUA) 是 UGT1 和 UGT2 家族酶最常用的辅因子,但 UGT2B7 和其他几种酶可以同时使用 UDP-GlcUA 和 UDP-葡萄糖 (UDP-Glc),导致形成葡萄糖醛酸和葡萄糖苷缀合物。对 UGT2B7 催化吗啡糖基化的研究表明,葡萄糖醛酸化是主要的代谢途径,因为 UDP-GlcUA 的结合亲和力高于 UDP-Glc。目前,尚不清楚 UGT2B7 辅因子结合域中的哪些残基负责 UDP-GlcUA 的优先结合。在这里,进行了分子动力学 (MD) 模拟,同时进行了定点突变和酶动力学研究,以确定 UGT2B7 结合位点中负责选择性辅因子结合的残基。MD 模拟表明,位于 N 端结构域内的精氨酸 259 与 UDP-GlcUA 特异性相互作用,其中精氨酸 259 的侧链与葡萄糖醛酸的羧基形成氢键和盐桥。与 MD 模拟一致,用亮氨酸取代 Arg259 导致吗啡、4-甲基伞形酮和齐多夫定的葡萄糖醛酸化活性丧失,但保留了吗啡的葡萄糖苷化。意义陈述:尽管尿苷二磷酸糖基转移酶 (UGT) 酶在药物和化学代谢中非常重要,但辅因子结合相互作用仍不完全清楚,UGT1 和 UGT2 家族酶优先进行葡萄糖醛酸化的分子基础也是如此。该研究表明,使用 UGT2B7 同源模型的长时间尺度分子动力学 (MD) 模拟可用于鉴定 UGT 蛋白与 UDP-糖辅因子的关键结合相互作用。此外,这些数据为 MD 模拟在阐明 UGT-配体相互作用中的应用提供了基础。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验